Recombinase Expression Vectors for Selective Polypeptide Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing technologies face limitations in selectively expressing genetically-encoded molecular tools in defined cellular sub-populations, hindering neuroscience research.
Innovation Solution
Recombinant expression vectors with coding sequences flanked by recombinase recognition sites, allowing for controlled modulation of polypeptide production through inversion or suppression using recombinases like Cre and Flp.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional expression vectors are used, then polypeptide production can be achieved, but selective expression in defined cellular sub-populations is limited
Solution Approach 1:
The expression vector is segmented into modular components: promoter region, coding sequence, and recombinase recognition sites (loxP or FRT). This segmentation allows independent optimization of each module and enables combinatorial assembly for different selective expression needs, directly improving adaptability while maintaining manageable complexity through standardization.
Solution Approach 2:
The vector incorporates dynamic control elements including inducible promoters and recombinase-dependent switching mechanisms that allow the expression system to transition between different states (off/on, cell-type specific). This dynamic capability enables selective expression in defined cellular sub-populations without requiring different static vector designs for each cell type.
2Ease of operation
If recombinase recognition sites are added to enable controlled expression, then selective modulation is improved, but vector structure becomes more complex
Solution Approach 1:
The vector design uses universal recombinase recognition sites (loxP for Cre recombinase, FRT for Flp recombinase) that can be applied across multiple different expression vectors and experimental systems. This universality provides controlled modulation capability across diverse applications while avoiding the need to design unique control mechanisms for each vector, thereby limiting the increase in overall complexity.
3Speed
If standard expression systems are used, then polypeptide production is achieved, but millisecond resolution control of action potentials is not possible
Solution Approach 1:
The patent introduces optogenetic tools as intermediary elements between light stimulation and neuronal action potentials. The expression vectors enable precise delivery of optogenetic proteins (channelrhodopsins, halorhodopsins) to specific neuronal populations, which then mediate millisecond-resolution control of action potentials through light-induced ion channel activity. This intermediary approach achieves high temporal precision while maintaining versatility in target cell selection.
Data Source
AI summary
The present disclosure provides recombinant expression vectors for modulating production of polypeptides of interest in a target cell or target cell population. Aspects of the disclosure include recombinant expression vectors having coding sequences encoding portions of a polypeptide of interest, where the coding sequences are flanked by recombinase recognition sites. Also provided are methods for using the recombinant expression vectors as well as a device for monitoring expression of the polypeptide of interest.